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The existence oftwo distinct dihydrofolate reductases (DHFR)in highly trimethoprim-resistant clinical isolates has been 
unequivocally demonstrated. The enzymes have been characterized with regard to the affinity for substrates and sensitivi- 
ty to inhibitors. The chromosomal, trimethoprim-sensitive DHFR was purified to homogeneity b a new simple two-step 
procedure. Its N-terminal amino acid sequence, determined up to the first 35 amino acids, showed 69%homology with 
the Escherichia coli DHFR. 
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1. INTRODUCTION 
Tr imethopr im (Tp)-resistance, which is fairly 
common in Enterobacteriaceae today, has recently 
also been found in staphylococci [1-3]. It is fre- 
quently associated with other resistances, such as 
methicil l in, gentamicin, erythromycin and others 
[3,4]. The Tp-resistance gene has been located on 
plasmids or on the chromosome [3,51. It mediates 
a high level of Tp-resistance (MIC _> 1000/zg/ml) 
due to the product ion of a new dihydrofolate 
reductase (DHFR).  The DHFR encoded by 
plasmid pSK1 was recently partially purif ied and 
designated as type S1 [6]. It is a monomer  of Mr = 
19700 and exhibits reduced sensitivity towards Tp. 
Neither the origin of the novel DHFR gene, nor the 
biochemical relationship of the gene product with 
the chromosomal staphylococcal DHFR or with 
DHFRs  from Gram-negative organisms is known. 
We recently embarked on a study of the 
mechanisms of Tp-resistance in multi-resistant 
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staphylococci f rom various countries, and we are 
reporting the purif ication and N-terminal mino 
acid sequence of the Tp-sensitive DHFR from 
Staphylococcus aureus. 
2. EXPERIMENTAL  
S. aureus ATCC 25923 is frequently used as a reference strain 
in susceptibility testing a d was taken from our strain collec- 
tion. S. aureus 853 and S. aureus 157/4696 are multiresistant 
clinical isolates, obtained from J. Braveny, Munich, and A.V. 
Graevenitz, Ziirich. Strains were identified by th ir growth on 
mannitol-salt-agar, coagulase and DNase reaction a d confirm- 
ed with the API-Staph system (API System SA). 
SDS-PAGE gels were run using the Mini-Protean II equip- 
ment (BioRad) and the bands visualized using a silver stain kit 
(BioRad). Protein solutions were concentrated using the Cen- 
tricon 10 system (Amicon). The DHFR assay was that of Bac- 
canari and Joyner [7]. The assay mixture contained 0.1 mM 
NADPH, 0.06 mM dihydrofolate and 1 mM 2-mercapto- 
ethanol in 50 mM imidazole-HCl buffer, pH 7.0. After addi- 
tion of the enzyme, the fall in A~0 was recorded using a 
Kontron Uvikon 860 spectrophotometer. A unit of DHFR ac- 
tivity was taken as the conversion of 1/zmol of dihydrofolate 
per minute. 
Amino acid sequence determination was performed on an 
Applied Biosystems 470 A gas-phase sequenator. The 
phenylhydantoin amino acids were identified as described by 
Lottspeich [8]. 
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Minimum inhibitory concentrations (MIC) for antibiotics 
were determined by agar dilution on Mueller Hinton Agar [9]. 
3. RESULTS 
3.1. DHFR-puri  fication 
S. aureus cells were grown in a 50 1 fermenter in 
L-broth. For S. aureus 853 10/~g/ml Tp was add- 
ed. Cells were broken by sonication after pretreat- 
ment with lysostaphin and lysozyme for 30 min at 
30°C in a 0.05 M phosphate buffer, pH 7.0. After 
centrifugation at 10000 x g for 30 min, the super- 
natant was dialyzed overnight against 10 mM Tris 
buffer, pH 6.8, at 4°C and then loaded onto a col- 
umn of Whatman DE-52 ion-exchange r sin (20 x 
1.7 cm). After washing with 5 column vols of buf- 
fer to remove non-bound proteins, the DHFR was 
eluted on a gradient of 0-0.25 M NaCl in the Tris 
buffer. 
The DHFR activity of the resistant strains was 
elated from the ion-exchange column in two peaks. 
In both cases the peak at 0.08 M NaC1 (DHFR I) 
was approx. 100 times less susceptible to inhibition 
by Tp than the peak at 0.13 M NaCI (DHFR II). 
The reference strain ATCC 25923 displayed only 
one peak of DHFR activity (DHFR II, the Tp- 
sensitive, chromosomal DHFR) which eluted at 
0.13 M NaCl. Fig. 1 shows typical elution profiles 
from the DE-52 column. The specific activity of 
the DHFR is increased ten-fold by this step, but 
the yield is low. It is not clear whether this 
represents a loss of protein on the column or an in- 
activation of the enzyme. 
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Fig. 1. Elution of DHFR activity from a DE-52 column with salt 
gradient. 
Table 1 compares the Tp-sensitivity of DHFR I 
and II and the antibiotic sensitivity of the three 
strains used in this study. Table 2 gives a more 
detailed comparison of the two DHFR types from 
strain 157/4696. 
Attempts to purify further the DHFR on a 
methotrexate (MTX) affinity column failed as 
both enzymes I and II bound too firmly. However, 
a Blue Sepharose column proved suitable for the 
Tp-sensitive peak II, with a recovery of 70°70 and 
a further 40-fold increase in specific activity. The 
pooled fractions from the DE-52 column were 
diluted with an equal volume of the Tris buffer, in 
order to lower the salt concentration, and loaded 
onto a 8 x 1.6 cm column of Blue Sepharose 
(Pharmacia). The majority of the bound protein 
could be eluted by washing with 0.1 M KCI in the 
Tris buffer, and the DHFR was specifically eluted 
by adding 2 mM folate. In fig.2 a silver stained 
SDS-PAGE gel is shown. From this a greater than 
95070 purity of DHFR II is deduced. It was relative- 
ly unstable in its purified form and tended to 
precipitate irreversibly on dialysis to a lower salt 
concentration. This was prevented by introducing 
the non-ionic detergent Nonidet P-40 as the salt 
was dialyzed out to render the solution suitable for 
N-terminal amino acid analysis. 
Table 1 
Antibiotic susceptibility of three S. aureus  strains and Tp 
sensitivity of DHFR I and II 
Strain MIC (ag/ml) a 'IC5o (aM) for Tp 
Tp Meth Pen DHFR I DHFR II 
ATCC 25923 0.5 2 0.06 - 0.043 
157/4696 > 1024 4 128 6.7 0.044 
853 512 64 128 7.0 0.062 
a Meth, methicillin; Pen, penicillin G 
Table 2 
Comparison of DHFR I and II from S. aureus 157/4696 
Property DHFR I DHFR II 
IC5o (Tp) 6.7 /zM 0.044 /~M 
ICso (MTX) 2.25 nM 1.1 nM 
Km (DHF) 3.0 /*M 4.0 /zM 
Km (NADPH) 9.9 /~M 6.3 /~M 
Ki (Tp) 0.88/~M 0.0094/~M 
Ki (MTX) 0.12 nM 0.011 nM 
Molecular mass 20 kDa 20 kDa 
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The Tp-resistant DHFR I could not be purified 
by the above method as it was not removed from 
the Blue Sepharose by salt concentrations up to 
1 M or folate up to 10 mM. It could be removed 
by chaotropic agents, but not specifically. Further 
efforts are being made to purify this enzyme. 
As can be seen from fig.2, the Tp-sensitive 
DHFR has a molecular mass of slightly under 
20 kDa. Although the resistant enzyme has not yet 
been purified, the two activities were not separable 
by gel-filtration chromatography, suggesting that 
DHFR I is also of this molecular mass. The above 
purification method was applied to the Tp- 
sensitive nzymes from all three strains with equal 
success, and is summarized in table 3. 
The purified, chromosomaily coded DHFRs 
were subjected to automated N-terminal amino 
acid analysis. Several sequencing runs were carried 
out and the sequence, as shown in fig.3 was 
established for S. aureus  157/4696. Identical 
amino acid sequences were found for strain ATCC 
94kDa 
67 
43 
30 
20.1 
14.4 
1 2 3 4 5 
Fig.2. Silver stained SDS-PAGE gel of  purified DHFR II from 
S. aureus 157/4696 eluted as described from the Blue Sepharose 
column (lanes 2,3,4). Lanes 1 and 5 are molecular mass 
standards. 
LETTERS December 1988 
Table 3 
Purification of S. aureus DHFRs 
Step Total Specific Yield 
activity activity (°70) 
(units) (U/rag) 
Crude extract 72.4 0.050 - 
DE-52 26.3 0.56 30.4 a 
Blue Sepharose 18.7 22.1 21.6 a 
a Yield based on total DHFR activity. The Tp-sensitive enzyme 
contributed between 60 and 80070 of the total activity 
25923 (sequenced up to residue 16) and strain 853 
(sequenced up to residue 24). 
4. DISCUSSION 
An efficient two-step method enabled us to 
purify several Tp-sensitive, chromosomally en- 
coded DHFRs to homogeneity. The highly 
hydrophobic nature of both staphylococcal en- 
zymes is unusual among DHFRs and necessitated 
the use of a non-ionic detergent, Nonidet NP-40, 
to prevent irreversible precipitation. Despite this 
difficulty, up to 35 amino acid residues could be 
determined and all strains showed an identical se- 
quence. A search for relationships to other known 
DHFRs showed best correlation with the Tp- 
sensitive, chromosomal E.  coi l  DHFR [10]. 15 
residues are identical, and considering conservative 
replacements according to Dayhoff et al. [11], 
there is a 69°70 sequence homology. 
The corresponding Tp-resistant DHFR I exhibits 
several interesting properties. It is only moderately 
resistant o Tp, highly sensitive to MTX and has 
the same size as the Tp-sensitive nzyme. It differs, 
however, in its affinity for Blue Sepharose and 
DE-52. One could speculate therefore that this 
plasmid-encoded enzyme has volved from the Tp- 
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Fig.3. Comparison of the N-terminal amino acid sequence of  S. aureus 157/4696 chromosomal DHFR and the E. coli DHFR taken 
from [10]. 
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sensitive staphylococcal DHFR and is not a totally 
different species, as are the most important Tp- 
resistant plasmid-derived DHFRs  from Gram- 
negatives [12]. Since the ICso values for Tp for the 
pSK1 DHFR (50/~M [6]) contrast with 6.7/~M for 
the Tp-resistant S. aureus 157/4696, it remains an 
open question at present whether more than one 
type of  plasmid-derived DHFRs  prevail in S. 
aureus, pSK1 DHFR has been isolated from 
Austral ian strains, our strains were isolates f rom 
Central Europe. These questions can only be 
resolved by further studies. Unfortunately, the 
resistant DHFR could not yet be purified suffi- 
ciently well with the technique applied to the Tp- 
sensitive enzyme. Since the gene for the Tp- 
resistant DHFR was found to reside on plasmids 
(unpublished), efforts to clone this gene and effi- 
ciently express it for better purif ication and 
characterization are now under way. 
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